ContractOmni Bio Pharmaceutical, Inc. • August 14th, 2012 • Biological products, (no disgnostic substances) • Colorado
PLEDGE AND SECURITY AGREEMENTPledge and Security Agreement • August 14th, 2012 • Omni Bio Pharmaceutical, Inc. • Biological products, (no disgnostic substances) • Colorado
THIS PLEDGE AND SECURITY AGREEMENT (this “Agreement”) is made as of this [___] day of May, 2012, by and between OMNI BIO PHARMACEUTICAL, INC., a Colorado corporation (“Omni”), and [“To be determined”], as collateral agent (the “Collateral Agent”) for the benefit of the persons named on Schedule 1 hereto as may be amended from time to time (each a “Secured Party”, and together, the “Secured Parties”).
SERIES A SENIOR SECURED 10% CONVERTIBLE PROMISSORY NOTE DUE ____, 2015 [36 months from the Issue Date]Omni Bio Pharmaceutical, Inc. • August 14th, 2012 • Biological products, (no disgnostic substances) • Colorado
THIS SERIES A SENIOR SECURED 10% CONVERTIBLE PROMISSORY NOTE (the “Convertible Note”) is one of a duly authorized issue of securities of OMNI BIO PHARMACEUTICAL, INC., a Colorado corporation, (the “Company”), designated as its Series A Senior Secured 10% Convertible Promissory Notes (the “Convertible Notes”) due on _________, 2015 [36 months from the Issue Date] (the “Maturity Date”), in an aggregate principal amount of up to $2.0 million plus accrued but unpaid interest.
AMENDMENT ONE TO SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • August 14th, 2012 • Omni Bio Pharmaceutical, Inc. • Biological products, (no disgnostic substances)
This Amendment made this 3rd day of July, 2012 by and between the THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate, contracting for and on behalf of the University of Colorado Denver, a public institution of higher education created under the Constitution and the Law of the State of Colorado (hereinafter referred to as “UNIVERSITY”) and Omni Bio Pharmaceutical, Inc. hereinafter referred to as “Sponsor”.
